Conference Description

October 1, 2005
Sheraton Chicago Northwest
3400 West Euclid Avenue
Arlington Heights, Illinois 60005
(847) 394-2000

Tell a friend about this conference
Download the brochure for this conference
See how attendees evaluated this conference

CME Credits 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this CME activity, the participant will be able to:

1. stratify patients with Acute Coronary Syndrome by risk and have a clearer understanding of conservative versus invasive treatment strategy with pharmacotherapy and catheter based protocols
2. utilize latest strategies to effectively manage patients with various forms of heart failure
3. evaluate, stage and manage patients with chronic kidney disease
4. understand the importance of pulmonary function testing (spirometry) and utilize the results in the diagnosis and treatment of COPD
5. more easily diagnose Bipolar Disorder, with the help of screening tools, and know when to utilize current treatment options or to refer
6. recognize risk factors for Hepatitis C and screen appropriately with a clearer understanding of treatment options available
7. recognize, diagnose and treat Non-Alcoholic Steatohepatitis
8. recognize when to start insulin therapy and identify ideal candidates for pre-mixed or basal-bolus insulin strategies, utilizing

Agenda:

7:45-8:10		Continental Breakfast and Registration
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Advances in the Diagnosis and Treatment of Acute Coronary Syndrome Alexandre Ferreira, MD
9:20-10:10		Congestive Heart Failure in Primary Care; Has The Treatment Regimen Changed? Steven Cohen, MD
10:10-10:30		Break/Vendor Area
10:30-11:20		Spirometry for the Primary Care Physician Nicholas Gross, MD
11:20-12:10		NASH : A Weighty Problem of Great Significance Norman Gitlin, MD
12:10-1:10		Lunch
1:10-2:00		Hepatitis C: An Approach to this Challenging Disease Norman Gitlin, MD
2:00-2:50		Bipolar Disorder in the Primary Care Setting: Recognition and Treatment Implications Roy Chengappa, MD
2:50-3:10		Break/Vendor Area
3:10-4:00		The Approach to the Patient with Chronic Kidney Disease Biff Palmer, MD
4:00-5:00		Effective Utilization of Insulin Therapy Steven Rabinowe, MD
5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Roy Chengappa, MD
Assistant Professor of Psychiatry
Western Psychiatric Institute and Clinic
University of Pittsburgh

Steven Cohen, MD
Chief of Congestive Heart Failure
Boca Raton Community Hospital
Partner, The Cardiology Center, Inc, Boca Raton, FL

Alexandre Ferreira, MD
Associate Professor of Clinical Medicine
at the University of Miami
Medical Director of Coronary Care Unit
at Jackson Memorial Hospital
Co-director of the Interventional Cardiology
Training Program

Norman Gitlin, MD
Professor of Medicine
Emory University
Atlanta,GA

Nicholas Gross, MD
Professor of Medicine at Stritch-Loyola School
of Medicine in Chicago
Member of the Attending Staff at Hines VA Hospital

Luigi Meneghini, MD, MBA
Associate Professor of Clinical Medicine, University of Miami
Associate Director for Clinical Affairs of
the Diabetes Research Institute
Co- Director of the State of Florida’s Southeastern
Florida Regional Diabetes Program

Biff Palmer, MD
Professor of Internal Medicine
Nephrology Fellowship Program Director
UT Southwestern Medical Center, Dallas, TX

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.0 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Axcan Pharma, Boehringer Ingelheim, Merck, Novartis, novo nordisk, Pfizer, Roche, sanofi-aventis.